Tian Zhang
Duke Cancer Institute

Last Updated On 11/4/2020 10:47:30 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
Company: Capio BioSciences
Recipient: An Immediate Family Member
Company: Archimmune Therapeutics
Recipient: An Immediate Family Member

Stock and Other Ownership Interests
Company: Capio Biosciences
Recipient: An Immediate Family Member
Company: Archimmune Therapeutics
Recipient: An Immediate Family Member
Company: Nanorobotics
Recipient: An Immediate Family Member

Honoraria
Company: Exelixis
Recipient: You
Company: Genentech/Roche
Recipient: You
Company: MJH Life Sciences
Recipient: You
Company: Pacific Genuity
Recipient: You

Consulting or Advisory Role
Company: Janssen
Recipient: You
Company: Genentech/Roche
Recipient: You
Company: Sanofi
Recipient: You
Company: Exelixis
Recipient: You
Company: AstraZeneca
Recipient: You
Company: Pfizer
Recipient: You
Company: Bristol-Myers Squibb
Recipient: You
Company: Foundation Medicine
Recipient: You
Company: Pharmacyclics
Recipient: You
Company: Amgen
Recipient: You
Company: Merck
Recipient: You
Company: Seattle Genetics
Recipient: You
Company: Dendreon
Recipient: You
Company: Calithera Biosciences
Recipient: You

Speakers' Bureau
Company: Exelixis
Recipient: You
Company: Genentech/Roche
Recipient: You
Company: Genomic Health
Recipient: You
Company: Sanofi/Aventis
Recipient: You

Research Funding
Company: Astellas Pharma
Recipient: You
Company: Janssen
Recipient: Your Institution
Company: Acerta Pharma
Recipient: Your Institution
Company: Pfizer
Recipient: Your Institution
Company: Merrimack
Recipient: Your Institution
Company: Stem CentRx
Recipient: Your Institution
Company: Novartis
Recipient: Your Institution
Company: OmniSeq
Recipient: Your Institution
Company: Personal Genome Diagnostics
Recipient: Your Institution
Company: Regeneron
Recipient: Your Institution
Company: Merck
Recipient: Your Institution
Company: Mirati Therapeutics
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
Please describe: Circulating tumor cell novel capture by c-MET technology
Recipient: Your Institution
Please describe: Prochelators as Targeted Prodrugs for Prostate Cancer
Recipient: Your Institution

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
Company: Acerta Pharma
Recipient: You
Company: Genomic Health
Recipient: You
Company: AstraZeneca
Recipient: You

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
No Relationships to Disclose